Một đêm kinh hoàng cho thị trường: Giữa bối cảnh thuế quan và cắt giảm lãi suất, liệu sự sống còn có phải là lựa chọn duy nhất?

Cyclica

company

About

Cyclica is the partner of choice for data-driven drug discovery.

Details

Last Funding Type
Grant
Last Funding Money Raised
$2.40M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
May 1, 2013
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Cyclica Inc.

Cyclica is the partner of choice for data-driven drug discovery. They advance molecules that embrace the complexity of the disease. They decentralize innovation with technology, build novel data-driven pipelines, and fuel cross-organizational collaborations at a molecular level.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
$26M $6.43M
Cyclica has raised a total of $26M $6.43M in funding over 2 rounds. Their latest funding was raised on Nov 15, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 15, 2022 Grant $2.40M 1 Bill & Melinda Gates Foundation Detail
Jun 24, 2020 Series B $23M 4 Drive Capital Detail
Jul 1, 2019 Series Unknown 1 Detail
Jul 26, 2017 Series A $2.25M 4 GreenSky Capital Detail
Sep 22, 2016 Series A $2.40M 2 GreenSky Capital Detail

Investors

Number of Lead Investors
Number of Investors
5
10
Cyclica is funded by 10 investors. Bill & Melinda Gates Foundation and Drive Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Bill & Melinda Gates Foundation Yes Grant
Drive Capital Yes Series B
Chiesi Pharmaceuticals Series B
GreenSky Capital Series B
Naheed Kurji Series B
EPIC Capital Series A
Hanhai Studio Series A
Uni-Innovate Group Series A
China Canada Angel Alliance Series A
StartUp Health Seed

Employee Profiles

Number of Employee Profiles
16
Cyclica has 16 current employee profiles, including Executive Naheed Kurji
Executive
Board member
Executive
Board member
Board member